CNL Healthcare Properties, Inc.
CHTH · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -5.08 | 2.48 | 1.07 | -0.45 |
| FCF Yield | 1.73% | 1.88% | 2.31% | 0.48% |
| EV / EBITDA | 2,275.15 | 49.37 | 49.01 | 51.68 |
| Quality | ||||
| ROIC | 12.25% | 0.84% | 0.70% | 0.52% |
| Gross Margin | 0.00% | 33.77% | 32.81% | 31.58% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 4.63% | 4.53% | 4.36% | 4.29% |
| Free Cash Flow Growth | -22.62% | -3.19% | 412.82% | -65.44% |
| Safety | ||||
| Net Debt / EBITDA | -282.82 | 22.25 | 24.37 | 26.64 |
| Interest Coverage | -0.86 | 0.87 | 0.77 | 0.57 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -38.78 | -39.62 | -40.75 |